For the quarter ended March 31, 2025, the SMA outperformed the Index on a gross-of-fees basis due to favorable stock selection. Stock selection in the communication services, consumer staples and ...

Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 eu ...

ImmutableX (IMX) is a cryptocurrency on the Ethereum blockchain that addresses scalability and throughput challenges faced by other cryptocurrencies. It achieves high throughput without compromising ...

Entering text into the input field will update the search result below Home page Seeking Alpha - Power to Investors Search for Symbols, analysts, keywords ...

At close: June 9 at 4:00:02 PM EDT ...

The prognosis of spinal muscular atrophy (SMA) depends on many factors, including disease type and severity, age at symptom onset, SMN2 gene copy number, genetic modifiers, and the therapeutic support ...

Get real-time stock quotes, market data, top gainers and losers, financial news, and market analysis. Track SPY, BTC/USD, NVDA, TSLA and more on Benzinga.com ...